Scientific Pioneer Featured in Wall Street Journal

A comprehensive article details how entrepreneur Cynthia Fisher ’83 is working to upend secretive practices in the medical industry.

During an August 2018 event, the article says, Fisher pitched President Donald Trump on her plan for forcing hospitals and doctors to disclose the pricing on deals they cut with insurers. The administration has included her idea in a broader policy statement, and it could issue a rule on the matter as early as May 3, according to the article.

Fisher is a founder and board member of Patient Rights Advocate and is best known for her pioneering work as Founder and CEO of ViaCord, Inc., a leading umbilical cord blood stem cell banking service which she started in 1993. In 2000, she co-founded and was president of the cellular medicines company, ViaCell, Inc. (VIAC).

A biology and physics major at Ursinus, Fisher also received an honorary Doctor of Science degree from Ursinus in 2006 in honor of her contributions to the college and to the business world. She has founded or co-founded several pioneering scientific and environmental companies that have had global impact

The Wall Street Journal article, available for subscribers, can be read here.